Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Healio1h
FDA grants approval to two more denosumab biosimilars
The FDA has approved two new denosumab biosimilars that are interchangeable with the reference medications Prolia and Xgeva, ...
Which Dow Jones Stock Is Cheaper, Amgen or Merck?
Four of the 30 stocks that make up the Dow Jones Industrial Average represent the healthcare sector. Within that group, ...
Senator Slams Pfizer (PFE) for “Biggest Tax-Dodging Scheme in Pharma History”
Senator Ron Wyden (D-Ore.), a senior member of the Senate Finance Committee, accused Pfizer (PFE) of carrying out what he ...
Managed Healthcare Executive17h
FDA Approves Two More Denosumab Biosimilars, Conexxence and Bomyntra
The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, ...
STAT18h
Wyden claims Pfizer used a ‘colossal’ scheme to avoid paying billions in U.S. taxes
Sen. Ron Wyden and other Democrats claim Pfizer used a "colossal" scheme to avoid paying billions in U.S. taxes.
Pfizer ran what could be the largest tax dodging scheme among Big Pharma: Senator
Reporting zero taxable profits in the U.S. in 2019, Pfizer (NYSE:PFE) carried out possibly the largest tax-avoidance scheme ...
PipelineReview.com21h
Fresenius Receives FDA Approval for their Denosumab Biosimilars and Secures Global Settlement Agreement
LAKE ZURICH, IL, USA I March 27, 2025 I Fresenius announced that the Biologics License Application (BLA) for the denosumab biosimilars Conexxence® ...